Home Cart Sign in  
Chemical Structure| 242478-37-1 Chemical Structure| 242478-37-1

Structure of Solifenacin
CAS No.: 242478-37-1

Chemical Structure| 242478-37-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Solifenacin is a competitive antagonist of muscarinic receptors that potently blocks signaling through M1, M2, and M3 with Kis of 25, 125, and 10 nM, respectively.

Synonyms: YM905 free base; YM905

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Solifenacin

CAS No. :242478-37-1
Formula : C23H26N2O2
M.W : 362.46
SMILES Code : C(O[C@@H]1C2CCN(C1)CC2)(=O)N3[C@H](C=4C(CC3)=CC=CC4)C5=CC=CC=C5
Synonyms :
YM905 free base; YM905
MDL No. :MFCD18910847
InChI Key :FBOUYBDGKBSUES-VXKWHMMOSA-N
Pubchem ID :154059

Safety of Solifenacin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H361
Precautionary Statements:P201-P202-P280-P308+P313-P405-P501

Isoform Comparison

Biological Activity

Target
  • mAChR

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Capacity-reduced bladder model Intra-arterial injection 10 μg/kg-0.1 mg/kg Single bolus Solifenacin significantly improved bladder compliance in the capacity-reduced bladder model, reduced voiding frequency, and increased voided volume. Front Pharmacol. 2021 May 26;12:657959

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01122563 Overactive Bladder COMPLETED 2025-01-11 Bandung, Indonesia|Jakarta, In... More >>donesia|Surabaya, Indonesia Less <<
NCT01018511 Benign Prostatic Hyperplasia ... More >> Lower Urinary Tract Symptoms Less << Phase 3 Completed - -
NCT01457573 Lower Urinary Tract Symptoms Phase 4 Completed - United States, Texas ... More >> The Methodist Hospital System Houston, Texas, United States, 77030 Less <<
NCT01021332 Lower Urinary Tract Symptoms ... More >> Benign Prostatic Hyperplasia Less << Phase 3 Completed - -
NCT01953861 EC905 Pharmac... More >>okinetics Healthy Subjects Less << Phase 1 Completed - United Kingdom ... More >> Parexel Early Phase Clinical Unit Harrow, United Kingdom, H1 3UJ Less <<
NCT00189800 Overactive Bladder Phase 3 Completed - Korea, Republic of ... More >> Anyang, Korea, Republic of Bucheon, Korea, Republic of Busan, Korea, Republic of Cheonan, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gwangju, Korea, Republic of Incheon, Korea, Republic of Seoul, Korea, Republic of Suwon, Korea, Republic of Less <<
NCT01018511 - Completed - -
NCT01767519 Overactive Bladder ... More >> Urinary Incontinence Less << Phase 3 Completed - United States, California ... More >> Newport Beach, California, United States Belgium Leuven, Belgium Canada, British Columbia Vancouver, British Columbia, Canada Canada, Ontario Toronto, Ontario, Canada Czech Republic Prague 6, Czech Republic Germany Berlin, Germany Poland Warsaw, Poland United Kingdom London, United Kingdom Less <<
NCT00441428 - Completed - Italy ... More >> University of L'Aquila L'Aquila, Abruzzo, Italy, 67100 Less <<
NCT01457573 - Completed - -
NCT01767519 - Completed - -
NCT01737918 Surgical Treatment of Urge Inc... More >>ontinence Less << Phase 1 Phase 2 Unknown July 2018 Germany ... More >> Abt. Beckenbodenchirurgie der Universitäts-Frauenklinik Köln Recruiting Köln, NRW, Germany, 50931 Contact: Wolfram H Jager, PhD    0049221478 ext 4900    wolfram.jaeger@uk-koeln.de    Abt. Beckenbodenchirurgie der Universitäts-Frauenklinik Köln Recruiting Köln, NRW, Germany, 50931 Contact: Wolfram H Jager, PhD    0049221478 ext 4900    wolfram.jaeger@uk-koeln.de    Contact: Peter Mallmann, PhD    0049221478 ext 4940    peter.mallmann@uk-koeln.de    Principal Investigator: Wolfram H Jager, PhD Less <<
NCT02494349 LUTS(Lower Urinary Tract Sympt... More >>oms) Benign Prostatic Hyperplasia Overactive Bladder Less << Phase 1 Completed - -
NCT01021332 - Completed - -
NCT01340027 Urologic Diseases ... More >> Urinary Bladder Diseases Urological Manifestations Signs and Symptoms Urinary Bladder, Overactive Less << Phase 2 Completed - -
NCT03038321 Non-Muscle-invasive Bladder Ca... More >>ncer (NMIBC) Bacillus Calmette-Guerin (BCG) Cystitis Intra-vesical Instillation Less << Phase 4 Active, not recruiting December 2019 Egypt ... More >> Urology and Nephrology Center Mansoura, Aldakahlia, Egypt, 35516 Less <<
NCT00826527 Urinary Frequency ... More >> Urinary Urgency Nocturia Less << Phase 4 Unknown - United States, Washington ... More >> Seattle Urology Research Center Recruiting Seattle, Washington, United States, 98166 Contact: Angel J Felipa, Coordinator    206-243-3701    surc@comcast.net    Principal Investigator: Jeffrey M Frankel, MD Less <<
NCT01639794 - Completed - Ireland ... More >> Site 2 - Mercy University Hospital Cork, Ireland Site: 4 - Tallaght Hospital Dublin, Ireland, 24 Site: 1 - St James Hopsital Dublin, Ireland, 8 Site: 5 - Beaumont Hospital Dublin, Ireland, 9 Site: 3 - Sligo General Hospital Sligo, Ireland Less <<
NCT00801944 Urinary Bladder, Overactive Phase 3 Completed - -
NCT00333112 Urinary Incontinence Phase 4 Completed - -
NCT01340027 - Completed - -
NCT00909428 Overactive Bladder Syndrome Phase 4 Completed - United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT00909428 - Completed - -
NCT00584090 Urinary Incontinence ... More >> Parkinson's Disease Less << Phase 4 Withdrawn(Study withdrawn with... More >> intent of persuing larger, multi-site study.) Less << - United States, Florida ... More >> University of South Florida Tampa, Florida, United States, 33612 Less <<
NCT01799902 Lower Urinary Tract Predominan... More >>t Storage Symptoms Less << COMPLETED 2025-10-13 ASZ, Aalst, 9300, Belgium|ZNA ... More >>Stuyvenberg, Antwerpen, 2060, Belgium|Erasme, Brussel, 1070, Belgium|UZ Brussel, Brussel, 1090, Belgium|Private practice, Brussel, 1180, Belgium|AZ St. Monica, Deurne, 2100, Belgium|UZ Antwerpen, Edegem, 2650, Belgium|Maria Middelares, Gent, 9000, Belgium|Sint-Lucas, Gent, 9000, Belgium|UZ Gent, Gent, 9000, Belgium|AZ Groeninge, Kortrijk, 8500, Belgium|AZ Damiaan, Oostende, 8400, Belgium|AZ Oudenaarde, Oudenaarde, 9700, Belgium|H.Hart Roeselaere, Roeselaere, 8800, Belgium|AZ Sint Elisabeth, Zottegem, 9620, Belgium Less <<
NCT00573508 Urinary Bladder, Overactive Phase 4 Completed - -
NCT00832650 Healthy Phase 1 Terminated(Protocol A0221057 w... More >>as terminated on December 25, 2009 for futility. There were no safety concerns related to this decision.) Less << - United States, Minnesota ... More >> Pfizer Investigational Site Rochester, Minnesota, United States, 55905 Less <<
NCT00832650 - Terminated(Protocol A0221057 w... More >>as terminated on December 25, 2009 for futility. There were no safety concerns related to this decision.) Less << - -
NCT01972841 - Completed - -
NCT02667470 Overactive Bladder PHASE4 COMPLETED 2025-05-13 Site: 1, Bangkok, 10330, Thail... More >>and Less <<
NCT01126424 Cognition Phase 4 Completed - United Kingdom ... More >> Blackpool, Lancashire, United Kingdom, FY2 0JH Manchester, Lancashire, United Kingdom, M50 2GY Bradford, Yorkshire, United Kingdom, BD3 0DQ Less <<
NCT00368706 Urinary Bladder, Overactive Phase 3 Completed - China ... More >> Beijing, China, 100000 Chong Qing, China, 404000 Hang Zhou, China, 310000 Shanghai, China, 200000 Less <<
NCT00852696 Overactive Bladder Phase 4 Completed - United States, Florida ... More >> Cleveland Clinic Florida Weston, Florida, United States, 33331 Less <<
NCT00510406 Lower Urinary Tract Symptoms ... More >> Prostatic Hyperplasia Less << Phase 2 Completed - -
NCT01972841 Urinary Bladder Overactive ... More >> Urinary Bladder Diseases\Urologic Diseases Overactive Bladder Urgency Incontinence Less << Phase 3 Completed - -
NCT01953848 EC905 Pharmac... More >>okinetics Multiple Dose Healthy Subjects Less << Phase 1 Completed - United Kingdom ... More >> Parexel Early Phase Clinical Unit Harrow, United Kingdom, H1 3UJ Less <<
NCT01126424 - Completed - -
NCT00454896 Urinary Bladder, Overactive Phase 3 Completed - -
NCT00573508 - Completed - -
NCT00629642 Multiple Sclerosis ... More >> Neurogenic Bladder Spinal Cord Diseases Less << Phase 4 Completed - -
NCT00699049 Urinary Bladder, Overactive Phase 4 Completed - Korea, Republic of ... More >> Cheonan, Korea, Republic of Pusan, Korea, Republic of Seoul, Korea, Republic of Less <<
NCT01908829 Urinary Bladder Diseases ... More >> Urinary Bladder Overactive Urologic Diseases Less << Phase 3 Completed - -
NCT00759577 Overactive Bladder PHASE4 TERMINATED 2025-05-10 -
NCT01908829 - Completed - -
NCT00771394 Benign Prostatic Hyperplasia ... More >> Benign Prostatic Hypertrophy Overactive Bladder Less << Phase 4 Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Shikoku, Japan Touhoku, Japan Less <<
NCT00759577 Overactive Bladder PHASE4 TERMINATED 2025-05-10 -
NCT02094703 Urinary Tract Infection Phase 4 Unknown December 2014 Indonesia ... More >> Cipto Mangunkusumo Hospital Recruiting Jakarta, Indonesia, 10430 Contact: Harrina Erlianti Rahardjo    +62 816-825-226    harrinaerlianti@yahoo.com Less <<
NCT02634489 Phase 1 Healt... More >>hy Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms Less << Phase 1 Completed - Netherlands ... More >> Site NL1 Zuidlaren, Drente, Netherlands, 9471 GP Less <<
NCT01381120 Flank Pain Ur... More >>inary Bladder, Overactive Less << Phase 4 Completed - Canada, Ontario ... More >> Barrie Urology Associates - The Male/Female Health and Research Centre Barrie, Ontario, Canada, L4M 7G1 Less <<
NCT01880619 Relieve of Ureteral Stent Symp... More >>toms Less << Phase 4 Completed - Egypt ... More >> Urology and Nephrology Center Mansoura, Egypt, 35516 Less <<
NCT00802373 Urinary Bladder, Overactive Phase 3 Completed - -
NCT01381120 - Completed - -
NCT01539707 Overactive Bladder ... More >> Neurogenic Detrusor Overactivity Less << Phase 1 Completed - Belgium ... More >> Site: 3201 Gent, Belgium, 9000 Canada, Quebec Québec City, Quebec, Canada, G1V 4G2 Denmark Site: 4501 Århus N, Denmark, DK-8200 Netherlands Site: 3102 Utrecht, Netherlands, 3584 EA Poland Site: 4801 Warszawa, Poland, 04-730 Turkey Site: 90 Ankara, Turkey, 6100 United Kingdom Site: 44 Sheffield, United Kingdom, S10 2TH Less <<
NCT01642277 Overactive Bladder PHASE2 COMPLETED 2025-08-14 Loyola University Chicago Heal... More >>th Sciences Division, Maywood, Illinois, 60153, United States Less <<
NCT03149809 Overactive Bladder ... More >> Parkinson Disease Less << Phase 3 Recruiting December 31, 2021 United States, Alabama ... More >> Birmingham VA Medical Center, Birmingham, AL Recruiting Birmingham, Alabama, United States, 35233 Contact: Galen Hale    205-933-8101 ext 5637    galen.hale@va.gov    Contact: Alayne D Markland, MD    2055587067 ext 6365    alayne.markland@va.gov    United States, Georgia Atlanta VA Medical and Rehab Center, Decatur, GA Recruiting Decatur, Georgia, United States, 30033 Contact: Elizabeth C Vaughan, MD MS    (404) 321-6111 ext 3710    elizabeth.vaughan2@va.gov    Principal Investigator: Elizabeth Camille Vaughan, MD MS          United States, Virginia Hunter Holmes McGuire VA Medical Center, Richmond, VA Recruiting Richmond, Virginia, United States, 23249 Contact: George Gitchel, PhD    804-675-6300    george.gitchel@va.gov    Contact: Jessica Lehosit, MD    8046755000 ext 1570    jessica.lehosit@va.gov Less <<
NCT00337558 Overactive Bladder ... More >> Urinary Incontinence Urge Incontinence Less << Phase 4 Completed - -
NCT01642277 Overactive Bladder PHASE2 COMPLETED 2025-08-14 Loyola University Chicago Heal... More >>th Sciences Division, Maywood, Illinois, 60153, United States Less <<
NCT00821184 Overactive Bladder Phase 3 Terminated(Insufficient subjec... More >>t availability/findings for data analysis) Less << - United States, Massachusetts ... More >> Lahey Clinic Burlington, Massachusetts, United States, 01805 Less <<
NCT00821184 - Terminated(Insufficient subjec... More >>t availability/findings for data analysis) Less << - -
NCT00507455 - Completed - -
NCT01314781 Overactive Bladder Phase 4 Completed - Switzerland ... More >> Blasenzentrum, Cantonal Hospital Frauenfeld, Thurgau, Switzerland, 8501 Less <<
NCT01262391 Urinary Bladder, Overactive Phase 1 Completed - Belgium ... More >> Ghent, Belgium, 9000 Kortrijk, Belgium, 8500 Denmark Arhus, Denmark, 8200 Sweden Goteborg, Sweden, 41685 Uppsala, Sweden, 75185 United Kingdom Cambridge, United Kingdom, CB2 2QQ Manchester, United Kingdom, M13 9WL Sheffield, United Kingdom, S10 2TH Less <<
NCT01018264 Overactive Bladder in Parkinso... More >>n's Disease Less << Phase 4 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 University of South Florida Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30329 Less <<
NCT01943487 Drug-Drug Interaction (DDI) ... More >> Healthy Subjects Less << Phase 1 Completed - France ... More >> SGS Aster Paris, France, 75015 Less <<
NCT01018264 - Completed - -
NCT00507455 Lower Urinary Tract Symptoms ... More >> Bladder Outlet Obstruction Less << Phase 2 Completed - -
NCT01638000 Urologic Diseases ... More >> Urinary Bladder, Overactive Urinary Bladder Diseases Less << Phase 3 Completed - -
NCT01595152 Urinary Bladder, Overactive Not Applicable Unknown May 2013 Israel ... More >> Rambam Health Care Campus Recruiting Haifa, Israel Contact: Lior Lowenstein, MD    048542382    lowensteinmd@gmailc.om    Hadassah Not yet recruiting Jerusalem, Israel Contact: David Shveiky, MD    97248542653    dshveiky@gmail.com    Principal Investigator: David Shveiky, MD          Belinson Not yet recruiting Petach Tikva, Israel Contact: Haim Krissi, MD    97248542653    haimkrissi@hotmail.com    Principal Investigator: Haim Krissi, MD          Asaf harofeh Not yet recruiting Tel Aviv, Israel Contact: Anna Padoa, MD    97248542653    annapadoa@gmail.com    Principal Investigator: Anna Padoa, MD          Rebecca Ziv Not yet recruiting Zefat, Israel Contact: Naama Marcus, MD    97248542653    naama.m@ziv.health.gov.il    Principal Investigator: Naama Marcus, MD Less <<
NCT01215721 - Completed - -
NCT00463541 Urinary Bladder, Overactive Phase 3 Completed - -
NCT00431041 - Completed - -
NCT02045862 Urinary Bladder Overactive ... More >> Overactive Bladder Urgency Incontinence Urinary Bladder Diseases\Urologic Diseases Less << Phase 3 Completed - -
NCT02010944 Phase 1 Bioav... More >>ailability Healthy Subjects Less << Phase 1 Completed - Germany ... More >> Parexel Berlin, Germany, 14050 Less <<
NCT02045862 - Completed - -
NCT00431041 Overactive Bladder Phase 4 Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada, T2V 4R6 Edmonton, Alberta, Canada, T5H 3V9 Canada, British Columbia Vancouver, British Columbia, Canada, V6T 2B5 Victoria, British Columbia, Canada, V8T 5G1 Canada, Nova Scotia Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Guelph, Ontario, Canada, N1H 5J1 Kitchener, Ontario, Canada, N2N 2B9 Toronto, Ontario, Canada, M4N 3M5 Toronto, Ontario, Canada, M5G 1Z5 Toronto, Ontario, Canada, M5T 2S8 Toronto, Ontario, Canada, M6A 3B5 Canada, Quebec Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT03558919 Overactive Bladder Phase 4 Completed - Bangladesh ... More >> Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh, 1100 Less <<
NCT01215721 Urinary Incontinence Not Applicable Completed - United States, California ... More >> University of California, Irvine Medical Center Orange, California, United States, 92868 Less <<
NCT01092624 Pelvic Organ Prolapse Phase 4 Terminated(sponsor closed stud... More >>y due to poor enrollment) Less << - United States, Connecticut ... More >> Hartford Hospital Hartford, Connecticut, United States, 06106 Less <<
NCT00581061 Incontinence Not Applicable Terminated(Study subjects were... More >> not compliant with study protocols.) Less << - United States, California ... More >> University of California, Irvine Medical Center Orange, California, United States, 92868 Less <<
NCT00979472 Urinary Bladder, Overactive|Ov... More >>eractive Bladder Less << PHASE4 COMPLETED 2025-06-10 Daegu, 700-712, Korea, Republi... More >>c of|Daegu, 705-718, Korea, Republic of|Daejon, 301-721, Korea, Republic of|Inchon, 400-711, Korea, Republic of|Jeonnam, 519-809, Korea, Republic of|Pusan, 602-739, Korea, Republic of|Seoul, 135-170, Korea, Republic of|Seoul, 135-705, Korea, Republic of|Seoul, 138-736, Korea, Republic of Less <<
NCT00581061 - Terminated(Study subjects were... More >> not compliant with study protocols.) Less << - -
NCT01747577 Overactive Bladder ... More >> Benign Prostate Hyperplasia Transurethral Resection of Prostate Photoselective Vaporization Prostatectomy Less << Phase 4 Completed - Korea, Republic of ... More >> Soul, Korea, Republic of Less <<
NCT02047032 Urinary Incontinence Not Applicable Completed - China ... More >> Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences Beijing, China, 100053 Less <<
NCT00454740 Urinary Bladder, Overactive Phase 3 Completed - -
NCT01638000 - Completed - -
NCT01423838 Overactive Bladder Phase 4 Unknown September 2012 Turkey ... More >> Turkish Republic Ministry of Health Adana Numune Training and Research Hospital Not yet recruiting Adana, Turkey, 01150 Contact: Murat Api, M.D., Ph.D.    +905424241807    muratapi@hotmail.com    Contact: Hakan Aytan, M.D.    +905056833866    drhakanaytan@yahoo.com Less <<
NCT01318837 Over Active Bladder Phase 4 Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of Sungnam, Korea, Republic of Less <<
NCT02180997 LUTS Benign P... More >>rostatic Hyperplasia Overactive Bladder Less << Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital(SNUH) Seoul, Jongno-Gu, Korea, Republic of, 110-744 Less <<
NCT01833663 Overactive Bladder ... More >> Postmenopausal Disorder Urination Disorders Less << Phase 4 Completed - China, Beijing ... More >> Peking Union Medical College Hospital Beijing, Beijing, China, 100730 Less <<
NCT01489709 - Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Shikoku, Japan Touhoku, Japan Less <<
NCT00773552 Urinary Urge ... More >>Urge Incontinence Overactive Bladder Less << Phase 4 Withdrawn(Investigator Left In... More >>stitution) Less << - United States, Connecticut ... More >> Optimus Health care Stamford, Connecticut, United States, 06904 The Stamford Hospital Stamford, Connecticut, United States, 06904 Less <<
NCT01565694 Neurogenic Detrusor Overactivi... More >>ty Less << Phase 3 Completed - United States, New York ... More >> Site US1008 Tarrytown, New York, United States, 10591 United States, Ohio Site US1010 Cincinnati, Ohio, United States, 45229-3039 Belgium Site BE3201 Gent, Belgium, 9000 Brazil Site BR5505 Sao Jose do Rio Preto, São Paulo, Brazil, 15090-000 Site BR5507 Campinas, Brazil, 13060-803 Site BR5504 Campinas, Brazil, 13083-887 Site BR5506 Curitiba, Brazil, 80240-060 Site BR5503 Porto Alegre, Brazil, 90035-903 Denmark Site DK4501 Aarhus, Denmark, 8200 Hungary Site HU3602 Miskolc, Hungary, 3526 Korea, Republic of Site KR8207 Seoul, Korea, Republic of, 110744 Site KR8201 Seoul, Korea, Republic of, 120752 Mexico Site MX5203 Leon, Mexico, 37000 Site MX5205 Mexico City, Mexico, C.P. 06700 Philippines Site PH6301 Manila, Philippines, 1015 Site PH6302 Quezon City, Philippines, 1101 Poland Site PL4803 Gdansk, Poland, 80-952 Site PL4805 Gdansk, Poland, 80803 Site PL4801 Warszawa, Poland, 04-730 Turkey Site TR9003 Ankara, Turkey, 6100 Site TR9002 Izmir, Turkey, 35100 Less <<
NCT01565707 Urinary Bladder, Overactive Phase 3 Completed - -
NCT01565707 - Completed - -
NCT01406158 Pharmacokinetics of Solifenaci... More >>n Succinate Healthy Volunteers Less << Phase 1 Completed - United States, Wisconsin ... More >> Spaulding Clinical Research West Bend, Wisconsin, United States, 53095 Less <<
NCT02715024 Lower Urinary Tract Symptoms ... More >> Overactive Bladder Benign Prostatic Hyperplasia (BPH) Less << Phase 4 Completed - Taiwan ... More >> Site Taipei, Taiwan Less <<
NCT02972268 Lower Urinary Tract Symptoms ... More >> Benign Prostatic Hyperplasia Less << Phase 3 Unknown December 2017 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Myung Soo Choo, MD., Ph.D Less <<
NCT03468465 Urinary Incontinence Phase 4 Active, not recruiting March 2019 Spain ... More >> Hospital Clínico Universtario Virgen de la Arrixaca El Palmar, Murcia, Spain, 30120 Less <<
NCT02087098 Urinary Bladder, Overactive COMPLETED 2025-03-16 Site CZ42003 Private Practice,... More >> Bene?ov, Czech Republic|Site CZ42001 Private Practice, Beroun, Czech Republic|Site CZ42014 Private Practice, Blansko, Czech Republic|Site CZ42023 Private Practice, Boskovice, Czech Republic|Site CZ42032 Private Practice, Brno, Czech Republic|Site CZ42034 Hospital, Brno, Czech Republic|Site CZ42035 Private Practice, Brno, Czech Republic|Site CZ42036 Private Practice, Brno, Czech Republic|Site CZ42038 Private Practice, Brno, Czech Republic|Site CZ42039 Private Practice, Brno, Czech Republic|Site CZ42058 Hospital, Brno, Czech Republic|Site CZ42059 Hospital, Brno, Czech Republic|Site CZ42025 Private Practice, Cheb, Czech Republic|Site CZ42048 Private Practice, Dv?r Králové, Czech Republic|Site CZ42040 Private Practice, Havlí?k?v Brod, Czech Republic|Site CZ42015 Private Practice, Hodonín, Czech Republic|Site CZ42045 Private Practice, Hradec Králové, Czech Republic|Site CZ42027 Private Practice, Jind?ich?v Hradec, Czech Republic|Site CZ42029 Private Practice, Jind?ich?v Hradec, Czech Republic|Site CZ42051 Private Practice, Ji?ín, Czech Republic|Site CZ42026 Private Practice, Karlovy Vary, Czech Republic|Site CZ42028 Private Practice, Karlovy Vary, Czech Republic|Site CZ42030 Private Practice, Klatovy, Czech Republic|Site CZ42049 Private Practice, Litomě?ice, Czech Republic|Site CZ42021 Private Practice, Litovel, Czech Republic|Site CZ42050 Private Practice, Most, Czech Republic|Site CZ42054 Private Practice, Ostrava, Czech Republic|Site CZ42055 Private Practice, Ostrava, Czech Republic|Site CZ42056 Private Practice, Ostrava, Czech Republic|Site CZ42057 Private Practice, Ostrava, Czech Republic|Site CZ42005 Private Practice, Pardubice, Czech Republic|Site CZ42008 Private Practice, Pardubice, Czech Republic|Site CZ42024 Private Practice, Plzeň, Czech Republic|Site CZ42011 Private Practice, Praha 10, Czech Republic|Site CZ42006 Private Practice, Praha 2, Czech Republic|Site CZ42010 Private Practice, Praha 4, Czech Republic|Site CZ42009 Private Practice, Praha 5, Czech Republic|Site CZ42004 Private Practice, Praha 7, Czech Republic|Site CZ42002 Private Practice, Praha 8, Czech Republic|Site CZ42007 Private Practice, Praha 8, Czech Republic|Site CZ42060 Private Practice, Praha, Czech Republic|Site CZ42044 Private Practice, Roudnice nad Labem, Czech Republic|Site CZ42031 Private Practice, Strakonice, Czech Republic|Site CZ42020 Private Practice, Svitavy, Czech Republic|Site CZ42047 Private Practice, Teplice, Czech Republic|Site CZ42053 Private Practice, Teplice, Czech Republic|Site CZ42042 Private Practice, Trutnov, Czech Republic|Site CZ42052 Private Practice, Turnov, Czech Republic|Site CZ42018 Hospital, Uherské Hradi?tě, Czech Republic|Site CZ42019 Private Practice, Uherské Hradi?tě, Czech Republic|Site CZ42041 Hospital, Velké Mezi?í?í, Czech Republic|Site CZ42016 Private Practice, Vsetín, Czech Republic|Site CZ42017 Private Practice, Vsetín, Czech Republic|Site CZ42012 Private Practice, Zlín, Czech Republic|Site CZ42013 Private Practice, Zlín, Czech Republic|Site CZ42022 Private Practice, Zlín, Czech Republic|Site CZ42033 Private Practice, Znojmo, Czech Republic|Site CZ42037 Hospital, Znojmo, Czech Republic|Site CZ42043 Private Practice, ústí nad Labem, Czech Republic|Site CZ42046 Private Practice, ústí nad Labem, Czech Republic Less <<
NCT02827578 Benign Prostate Hyperplasia Phase 3 Unknown December 2017 Korea, Republic of ... More >> Samsung medical center Recruiting Seoul, Korea, Republic of Principal Investigator: Kyu Sung Lee Less <<
NCT02805452 Overactive Bladder Phase 3 Terminated(Target of recruitme... More >>nt not reachable) Less << - France ... More >> Clinique Pasteur Lanroze Brest, France CH Bretagne Sud Lorient, France CH Lyon Sud Lyon, France Hôpital Saint Louis Paris, France Centre Eugene Marquis Rennes, France, 35042 Less <<
NCT01297192 Healthy Volunteers ... More >> Pharmacokinetics of Mirabegron Less << Phase 1 Completed - France ... More >> Paris, France, 75015 Less <<
NCT01777217 Over-Active Bladder Phase 4 Terminated(Terminated) - United States, Texas ... More >> Century Cancer Center Houston, Texas, United States, 77025 Less <<
NCT01745094 - Completed - -
NCT01777217 - Terminated(Terminated) - -
NCT01745094 Overactive Bladder Phase 4 Completed - Japan ... More >> Chubu, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Less <<
NCT01371994 Urinary Incontinence Phase 4 Completed - -
NCT01533597 Overactive Bladder Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 Less <<
NCT01533597 - Completed - -
NCT01371994 - Completed - -
NCT01093534 Detrusor Overactivity ... More >> Overactive Bladder Less << Phase 4 Completed - -
NCT01876186 Overactive Bladder Syndrome Phase 4 Unknown December 2015 Taiwan ... More >> Department of Obstetrics & Gynecology, National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ho-Hsiung Lin, MD, PhD    +886-2-23123456 ext 71557    hhlin@ntuh.gov.tw    Principal Investigator: Ho-Hsiung Lin, MD, PhD Less <<
NCT02169713 Healthy Subjects ... More >> Pharmacokinetics Drug-Drug Interaction (DDI) Less << Phase 1 Completed - Germany ... More >> Parexel International GmbH Berlin, Germany, 14050 Less <<
NCT01093534 - Completed - -
NCT00884104 Overactive Bladder PHASE4 COMPLETED 2025-12-10 Cheon-ju, Korea, Republic of|C... More >>hoongju, Korea, Republic of|Daegu, Korea, Republic of|Daejeon, Korea, Republic of|Kangneung, Korea, Republic of|Kwang-ju, Korea, Republic of|Pusan, Korea, Republic of|Seoul, Korea, Republic of|Suwon, Korea, Republic of Less <<
NCT01470001 Post-micturition Incontinence ... More >> Incontinence Less << Not Applicable Completed - United States, Wisconsin ... More >> UW Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT01953887 EC905 Pharmac... More >>okinetics Healthy Subjects Less << Phase 1 Completed - United Kingdom ... More >> Parexel London, United Kingdom, HA1 3UJ Less <<
NCT02540707 Overactive Bladder Syndrome Phase 4 Unknown September 2016 Taiwan ... More >> Outpatient clinics, Department of Obs/Gyn, National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ho-Hsiung Lin, MD, PhD    +886-2-23123456 ext 71557    hhlin@ntuh.gov.tw Less <<
NCT01470001 - Completed - -
NCT01505439 Stress Urinary Incontinence ... More >> Urgency Urinary Incontinence Less << Phase 4 Completed - Korea, Republic of ... More >> Site KR00001 Chonam, Korea, Republic of Site KR00002 Chungnam, Korea, Republic of Site KR00003 Daegu, Korea, Republic of SIte KR00004 Incheon, Korea, Republic of Site KR00005 Pusan, Korea, Republic of Site KR00006 Seoul, Korea, Republic of Less <<
NCT02127034 Healthy Subjects ... More >> Pharmacokinetics Drug-Drug Interaction (DDI) Less << Phase 1 Completed - Germany ... More >> Parexel International GmbH Berlin, Germany, 14050 Less <<
NCT01530373 Hot Flashes B... More >>reast Cancer Less << Phase 2 Recruiting September 2021 United States, Arkansas ... More >> Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 722205 Contact: Allen C Sherman, PhD    501-686-8700    shermanallenc@uams.edu    Sub-Investigator: Issam Makhoul, MD          Sub-Investigator: Laura Hutchins, MD          Sub-Investigator: Rhonda Henry-Tillman, MD Less <<
NCT01764893 Overactive Bladder Phase 4 Terminated(Enrolling too slowl... More >>y due to insurance plans no longer covering the cost of the Percutaneous Tibial Nerve Stimulation treatment.) Less << - United States, Massachusetts ... More >> Bay State Clinical Trials, Inc. Watertown, Massachusetts, United States, 02472 Less <<
NCT01437670 - Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-222 Less <<
NCT01015040 Bioavailability of Solifenacin... More >> Succinate Pharmacokinetics of Solifenacin Succinate Healthy Volunteers Less << Phase 1 Completed - United States, Wisconsin ... More >> West Bend, Wisconsin, United States, 53095 Less <<
NCT01981954 Neurogenic Detrusor Overactivi... More >>ty Pediatric Less << Phase 3 Completed - United States, New York ... More >> Site US1008 Pediatric Urology Associates, P.C. Tarrytown, New York, United States, 10591 Belgium Site BE3203 Gent University Hospital Gent, Belgium, 9000 Korea, Republic of Site KR8207 Seoul National University Hospital Seoul, Korea, Republic of, 110744 Site KR8201 Severance Hospital Seoul, Korea, Republic of, 120752 Philippines Site PH6301 Philippines Children's Medical Center Manila, Philippines, 1015 Poland Site PL4803 Uniwersyteckie Centrum Kliniczne Gdansk, Poland, 81-211 Site PL4801 Pomnik-Centrum Zdrowia Dziecka Warszawa, Poland, 04-730 United Kingdom Site GB4401 Sheffield Children's Hospital Sheffield, United Kingdom, S10 2TN Less <<
NCT00985387 Urinary Bladder, Overactive|Ov... More >>eractive Bladder Less << COMPLETED 2025-08-11 Bucheon, 420-717, Korea, Repub... More >>lic of|Bucheon, 420-767, Korea, Republic of|Busan, 602-702, Korea, Republic of|Busan, 602-715, Korea, Republic of|Busan, 602-739, Korea, Republic of|Busan, 614-735, Korea, Republic of|Chonju, 361-711, Korea, Republic of|Chonju, 380-704, Korea, Republic of|Chuncheon, 200-704, Korea, Republic of|Daegu, 700-712, Korea, Republic of|Daegu, 700-721, Korea, Republic of|Daegu, 705-717, Korea, Republic of|Daegu, 705-718, Korea, Republic of|Daejeon, 301-721, Korea, Republic of|Daejeon, 302-718, Korea, Republic of|Daejeon, 302-799, Korea, Republic of|Gangneung, 201-711, Korea, Republic of|Gumi-si, 730-728, Korea, Republic of|Gwangju, 501-717, Korea, Republic of|Gwangju, 501-757, Korea, Republic of|Gwangju, 503-715, Korea, Republic of|Gyongju, 780-350, Korea, Republic of|Hwasun, 519-809, Korea, Republic of|Iksan, 570-160, Korea, Republic of|Inchon, 400-711, Korea, Republic of|Inchon, 405-760, Korea, Republic of|Jeonju, 561-712, Korea, Republic of|Masan, 630-522, Korea, Republic of|Seongnam, 463-707, Korea, Republic of|Seoul, 100-380, Korea, Republic of|Seoul, 110-744, Korea, Republic of|Seoul, 130-702, Korea, Republic of|Seoul, 133-792, Korea, Republic of|Seoul, 136-705, Korea, Republic of|Seoul, 137-701, Korea, Republic of|Seoul, 138-736, Korea, Republic of|Seoul, 139-711, Korea, Republic of|Seoul, 143-729, Korea, Republic of|Seoul, 158-710, Korea, Republic of|Suwon, 443-721, Korea, Republic of|Ulsan, 682-714, Korea, Republic of Less <<
NCT01655069 - Completed - -
NCT01981954 - Completed - -
NCT01655069 Urinary Bladder, Overactive Phase 3 Completed - -
NCT03632772 Overactive Bladder Syndrome Phase 2 Recruiting July 31, 2019 Taiwan ... More >> Buddhist Tzu Chi General Hospital Recruiting Hualien city, Taiwan, 970 Contact: Hann-Chorng Kuo, M.D.    886-3-8561825 ext 2113    hck@tzuchi.com.tw Less <<
NCT01627145 Overactive Bladder Syndrome UNKNOWN 2025-07-15 No 8, Chung-Shan South Road,, ... More >>Taipei, 100, Taiwan Less <<
NCT01559389 Urge Urinary Incontinence PHASE4 COMPLETED 2017-06-29 Loyola University Medical Cent... More >>er, Maywood, Illinois, 60153, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.76mL

0.55mL

0.28mL

13.79mL

2.76mL

1.38mL

27.59mL

5.52mL

2.76mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories